Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2006; 12(8): 1255-1260
Published online Feb 28, 2006. doi: 10.3748/wjg.v12.i8.1255
Published online Feb 28, 2006. doi: 10.3748/wjg.v12.i8.1255
Table 2 Clinical data in individuals with reactivity to "anti-HBc alone"
| HBV-DNA-PCR in serum1 | |||
| Positive | Negative | ||
| n | 44 | 501 | |
| Males/females2 | 27/17 | 336/163 | |
| Age (mean ± SD) | 57.2 ± 18.6 | 58.5 ± 16.2 | |
| ALT2 | Normal | 23/35 (65.7%) | 251/402 (62.4%) |
| ≤Twofold increase | 7/35 (20.0%) | 81/402 (20.1%) | |
| > Twofold increase | 5/35 (14.3%) | 70/402 (17.4%) | |
| Liver ultrasound2 | no pathological findings | 5/11 (45.5%) | 112/204 (54.9%) |
| Steatosis | 5/11 (45.5%) | 63/204 (30.9%) | |
| Cirrhosis | 0/11 | 20/204 (9.8%) | |
| Carcinoma | 1/11 (9.1%) | 9/204 (4.4%) | |
| Liver histology2 | No pathological findings | 0/2 | 5/42 (11.9%) |
| Viral inflammation | 1/2 (50%) | 7/42 (16.7%) | |
| Steatosis | 0 /2 | 3/42 (7.1%) | |
| Cirrhosis | 0 /2 | 17/42 (40.5%) | |
| Carcinoma | 1/2 (50%) | 10/42 (23.8%) | |
| Anti-HBs titer (IU/L) | 1.9 ± 2.5 | 2.6 ± 3.0 | |
| Anti-HBe pos/n tested | 6/9 (66.7%) | 53/138 (38.4%) | |
| Anti-HCV pos/n tested | 7/44 (15.9%) | 103/500 (20.6%) | |
| Anti-HIV pos/n tested | 0/43 (0 %) | 17/491 (3.5%) | |
- Citation: Knöll A, Hartmann A, Hamoshi H, Weislmaier K, Jilg W. Serological pattern “anti-HBc alone”: Characterization of 552 individuals and clinical significance. World J Gastroenterol 2006; 12(8): 1255-1260
- URL: https://www.wjgnet.com/1007-9327/full/v12/i8/1255.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i8.1255